← FDA Drug Approvals (Drugs@FDA)

ADZENYS ER

NDA · New Drug Application · Sponsor: NEOS THERAPS INC · Approved 2017-09-15

Drug application

FDA Application #

NDA204325

Application type

New Drug Application

Brand name

ADZENYS ER

Generic name

Amphetamine

Active ingredients

AMPHETAMINE

Dosage form

SUSPENSION, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

NEOS THERAPS INC

First approval

2017-09-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown